| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 2 | — | — | — | 1 | — | — | 6 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡‡ |
|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 1.65 |
—
—
—
|
| 2025 | 1.65 |
—
—
—
—
|
| 2024 | 1.46 |
—
—
—
—
|
| 2023 | 1.29 |
—
—
—
—
|
| 2022 | 1.15 |
—
—
—
—
|
| 2021 | 1.04 |
—
—
—
—
|
| 2020 | 0.23 |
—
|
| 2019 | 0.89 |
—
—
—
—
|
| 2018 | 0.74 |
—
—
—
—
|
| 2017 | 0.60 |
—
—
—
—
|
| 2016 | 0.50 |
—
—
—
—
|
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Cash | 5,600.00 | 5,335.00 | 6,230.00 | 6,004.00 |
| Receivables | 588.00 | 618.00 | 610.00 | 733.00 |
| Inventory | 5,965.00 | 6,421.00 | 7,297.00 | 7,862.00 |
| Other | — | — | — | — |
| 12,664.00 | 12,991.00 | 15,202.00 | 15,329.00 |
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Payables | 3,862.00 | 4,257.00 | 4,575.00 | 5,024.00 |
| ST’ Debt | — | — | 999.00 | 1,000.00 |
| Other | — | — | — | — |
| 10,451.00 | 11,008.00 | 13,361.00 | 13,360.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 14,323.00 | 15,180.00 | — | — |
—
|
| ’26 | 13,111.00 | 14,401.00 | 15,117.00 | 17,743.00 |
60,372.00
|
| ’25 | 12,479.00 | 13,468.00 | 14,063.00 | 16,350.00 |
56,360.00
|
| ’24 | 11,783.00 | 12,758.00 | 13,265.00 | 16,411.00 |
54,217.00
|
| ’23 | 11,406.00 | 11,843.00 | 12,167.00 | 14,520.00 |
49,936.00
|
| ’22 | 10,086.66 | 12,077.06 | 12,531.89 | 13,854.39 |
48,550.00
|
| ’21 | 4,408.89 | 6,667.58 | 10,117.29 | 10,943.25 |
32,137.00
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 1,119.00 | 2,226.00 | — | — |
—
|
| ’26 | 394.00 | 1,791.00 | 1,532.00 | 3,157.00 |
6,874.00
|
| ’25 | 737.00 | 1,629.00 | 1,046.00 | 2,704.00 |
6,116.00
|
| ’24 | 745.00 | 1,341.00 | 1,171.00 | 2,800.00 |
6,057.00
|
| ’23 | (634.00) | 640.00 | 1,053.00 | 3,025.00 |
4,084.00
|
| ’22 | (432.73) | 1,379.61 | 1,000.05 | 1,110.07 |
3,057.00
|
| ’21 | (3,160.48) | 3,357.26 | 4,079.99 | 285.24 |
4,562.00
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 457.00 | 1,729.00 | — | — |
—
|
| ’26 | (103.00) | 1,330.00 | 1,001.00 | 2,689.00 |
4,917.00
|
| ’25 | 318.00 | 1,066.00 | 624.00 | 2,190.00 |
4,198.00
|
| ’24 | 384.00 | 882.00 | 711.00 | 2,358.00 |
4,335.00
|
| ’23 | (948.00) | 261.00 | 646.00 | 2,668.00 |
2,627.00
|
| ’22 | (658.02) | 1,159.96 | 729.46 | 780.61 |
2,012.00
|
| ’21 | (3,371.01) | 3,257.87 | 3,956.29 | 150.84 |
3,994.00
|
| Apr | Jul | Oct | Jan | Year | |
|---|---|---|---|---|---|
| ’26 | 1.19 | 1.36 | — | — |
—
|
| ’26 | 0.92 | 1.10 | 1.28 | 1.58 |
4.87
|
| ’25 | 0.93 | 0.96 | 1.14 | 1.23 |
4.26
|
| ’24 | 0.76 | 0.85 | 1.03 | 1.22 |
3.86
|
| ’23 | 0.49 | 0.69 | 0.91 | 0.89 |
2.97
|
| ’22 | 0.44 | 0.64 | 0.84 | 0.78 |
2.70
|
| ’21 | (0.74) | (0.18) | 0.71 | 0.27 |
0.07
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.69 | 72.92 | 91.31 | 112.10 | 122.78 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 81.17 | 94.29 | 128.00 | 157.83 | 170.00 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 340,000 | 329,000 | 349,000 | 364,000 | 377,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.14 | 0.15 | 0.16 | 0.15 | 0.16 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 48,550.00 | 49,936.00 | 54,217.00 | 56,360.00 | 60,372.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.50% | 27.61% | 30.00% | 30.60% | 30.96% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,398.00 | 4,636.00 | 5,967.00 | 6,483.00 | 7,299.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.06% | 9.28% | 11.01% | 11.50% | 12.09% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,283.00 | 3,498.00 | 4,474.00 | 4,864.00 | 5,494.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,057.00 | 1,009.00 | 1,124.00 | 1,287.00 | 1,461.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.46 | 42.83 | 47.31 | 49.96 | 54.19 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.70 | 2.97 | 3.86 | 4.26 | 4.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.55 | 3.50 | 5.29 | 5.42 | 6.17 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.87) | (1.25) | (1.50) | (1.70) | (1.76) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.68 | 2.25 | 3.78 | 3.72 | 4.41 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.00 | 5.46 | 6.37 | 7.44 | 9.15 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,200.00 | 1,166.00 | 1,146.00 | 1,128.00 | 1,114.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.66 | 27.47 | 24.59 | 29.29 | 30.77 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.78 | 1.91 | 2.01 | 2.50 | 2.77 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.39 | 15.00 | 14.90 | 16.77 | 16.42 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.75 | 1.87 | 1.99 | 2.48 | 2.72 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.28 | 35.53 | 24.85 | 33.34 | 33.34 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,057.00 | 4,084.00 | 6,057.00 | 6,116.00 | 6,874.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,045.00) | (1,457.00) | (1,722.00) | (1,918.00) | (1,957.00) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,012.00 | 2,627.00 | 4,335.00 | 4,198.00 | 4,917.00 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,791.00 | 2,151.00 | 2,213.00 | 1,983.00 | 1,841.00 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,932.00 | 3,359.00 | 2,862.00 | 2,866.00 | 2,869.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,295.00) | (2,118.00) | (2,738.00) | (2,469.00) | (3,361.00) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6,003.00 | 6,364.00 | 7,302.00 | 8,393.00 | 10,190.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.08% | 12.31% | 15.40% | 15.82% | 16.27% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 63.12% | 71.54% | 79.38% | 66.49% | 65.69% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.48% | 56.57% | 65.48% | 61.98% | 59.13% | — | — | — |
ROE
|
TJX Companies has delivered impressive revenue growth, surging 75% from $30.9 billion in 2016 to $54.2 billion in 2024, fueled by store expansions and operational efficiency with revenue per employee stabilizing around $155,000. Post-COVID rebound was sharp—51% YoY growth in 2022—driving EPS up 123% to $3.86 and elite ROIC of 79.4%, supported by aggressive buybacks reducing shares 15%. Analysts project continued momentum: 4% YoY revenue growth to $56.4 billion in 2025 and $67.6 billion by 2028, with EPS hitting $5.73 (48% cumulative gain).
Yet red flags abound. The stock trades at the low end of analyst targets (0% implied upside, 10% below mean), with premium valuations—PE at 24.6 rising to 29.3, PS at 2.01, PB at 14.9—pricing in perfection amid rising capex to $1.9 billion and consumer debt at $17.5 trillion. Insider activity screams caution: zero buys in 12 months, over $14 million in C-suite sells, including CEO dumping 95k+ shares at peaks.
A contrarian lens highlights vulnerabilities—cyclical reliance on discretionary spending, tariff risks, e-commerce competition, and recession odds as confidence nears 2020 lows—potentially derailing 4-6% CAGR bets. While fundamentals dazzle on recovery metrics, this poised pullback at no margin of safety warrants scrutiny.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.